> 매일 아침 research-watcher가 27개 query family × PubMed/GEO를 스캔해서, Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. 매일 06:00 KST 자동 생성. **Category focus:** Bioinformatics & Multi-Omics **Published:** 2026-08-09 06:04 KST **Entry ID:** 64 **Tags:** #gse277080 #spatial-transcriptomics #reproducibility #gse328422 #lymph-node-metastasis #single-cell #gse292589 #ipf #pulmonary-fibrosis #myeloid #interferon #bioinformatics --- ## 🔬 Today's Top Findings ### 1. Spatial-transcriptomics reproducibility metrics ### 2. lymph-node metastasis immune dynamics ### 3. and IPF myeloid-state data (GSE277080, GSE328422, GSE292589) ## 📋 Synthesis The 2026-08-09 research-watcher scan completed successfully with 105 hits across 27 query families. Three actionable signals survived BB-domain filtering: standardized imaging-based spatial-transcriptomics metrics (GSE277080), spatio-temporal immune-cell mapping during sequential lymph-node metastasis (GSE328422), and an IPF single-cell dataset linking type-I-interferon-activated myeloid states with less-fibrotic disease stages (GSE292589). These are hypothesis-generation datasets, not clinical efficacy evidence. Combined four-axis score (peptide / AI-agent infrastructure / longevity / cost): 7/12, 8/12, and 8/12. Novelty gate: NOVEL 3/3 versus yesterday's top digest entries. --- ## 🎯 Highlights ### 1. Signal 1 — Bioinformatics & Multi-Omics / spatial-transcriptomics quality: GSE277080 provides 38 human samples and downloadable CSV/TAR material for benchmarking standardized metrics and reproducibility across imaging-based spatial-transcriptomics datasets. Score 7/12. Why it matters for BB: it can become the QC gate used before cross-platform spatial-model comparisons. ### 2. Signal 2 — AI Drug Discovery + Bioinformatics / refractory-cancer immune geography: GSE328422 maps immune-cell dynamics across sequential human lymph-node metastasis with H5, Parquet, RDS, and TIFF files. Score 8/12. Why it matters for BB: reconstructing cell-state transitions can nominate metastasis-stage biomarkers and targetable immune bottlenecks. ### 3. Signal 3 — Clinical & Regulatory + Bioinformatics / IPF: GSE292589 is a human single-cell dataset associating type-I-interferon-activated myeloid states with less-fibrotic IPF stages. Score 8/12. Why it matters for BB: its interferon/myeloid signatures can be benchmarked against the anti-fibrotic reference panel, while avoiding unsupported treatment-response claims. ### 4. Novelty and action gate — All three accessions are absent from yesterday's top entry (NOVEL 3/3). Prioritize GSE292589 for the IPF lane, use GSE328422 to extend the refractory-cancer metastasis atlas, and use GSE277080 to standardize spatial-data QC across both workflows. --- ## 💼 Next Steps - **[Open GSE277080 (spatial-transcriptomics metrics)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277080)** - **[Open GSE328422 (lymph-node metastasis atlas)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328422)** - **[Open GSE292589 (IPF myeloid atlas)](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292589)** - **[Request an IPF + spatial-QC brief](https://brownbio.tech/services/ai-drug-discovery#brief)** --- ## 📡 Provenance - **Source:** research-watcher (PubMed/GEO scan, 27 query families × Brown Biotech pipelines) - **Pipeline:** [`brown-biotech-daily-tech-digest`](https://github.com/ohbryt/brown-biotech-platform) — 06:00 KST cron - **Generated:** 2026-08-09 06:04 KST - **Repo:** `ohbryt/brown-biotech-platform` --- _Auto-published by `brown_biotech_research_digest_publisher.py` · [brownbio.tech](https://brownbio.tech) · Decision-ready research, daily._
Brown Biotech Research Digest — 2026-08-09
PubMed/GEO scan · research-watcher · 06:00 KST